HOME >> MEDICINE >> NEWS
Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents

In the first published trial of its kind, a multi-center clinical study has shown that drug-eluting stents outperform the current "gold standard" radiation treatment in managing coronary restenosis and in preventing further clogging of coronary arteries.

Results of the TAXUS Express stent trial led by Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia were published in the March 15 issue of the Journal of the American Medical Association. The study results were also presented March 12 at the American College of Cardiology's annual scientific meeting in Atlanta.

The trial studied 396 patients whose bare metal stents had become clogged with scar tissue, a common complication called restenosis. About half of the patients received paclitaxel-eluting stents, while the other half received vascular brachytherapy, which delivers radiation to the inside of the artery via a catheter. Vascular brachytherapy is currently the only FDA-approved treatment for restenosis after bare metal stent implantation. Paclitaxel is a drug that inhibits cell migration and prevents restenosis. The TAXUS Express stent is made by Boston Scientific Corp.

After 9 months, the trial showed that the paclitaxel-eluting stents reduced by 40 percent the number of patients needing additional procedures to clear the artery, compared to vascular brachytherapy. Angiographic measurements in both groups showed that patients who had drug-eluting stents experienced less than half as much restenosis (14.5 percent) as those who had brachytherapy (31.2 percent).

The trial also showed that the benefits of paclitaxel-stenting were achieved without compromising safety. Paclitaxel stents reduced major cardiac events from 20.1 percent in the brachytherapy group to 11.5 percent. The two treatments had similar rates of cardiac death or myocardial infarction (5.2 percent for brachytherapy and 3.7 percent for stenting) and thrombosis in the stented artery
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
12-Mar-2006


Page: 1 2

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Drug-eluting and absorbable stents push interventional frontiers
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. New biodegradable magnesium stents for coronary arteries
7. Bare-metal stents are better for some heart patients
8. Off-label and untested use of drug-coated stents appears widespread
9. Studies highlight real world use, safety of drug-eluting stents
10. Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes
11. SCAI issues clinical alert on drug-eluting stents and late thrombosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2020)... ... 20, 2020 , ... My heart goes out to those across our nation ... a loved one recently through similar circumstances - underlying conditions compounded by a virus ... a gamut of negative emotions just like many have: fear, anxiety, uncertainty. In contrast, ...
(Date:3/20/2020)... ... March 20, 2020 , ... The primary objective ... researchers in machine learning, bioinformatics, immunology, virology and vaccine design to create open ... "The COVID-19 crisis gives us an opportunity and a profound motivation to act ...
(Date:3/19/2020)... ... ... Therapies of The Rockies has Colorado’s back, and they are here to support ... across the country, as remote therapy services have no geographic boundaries. Reach out to ... safely! , Therapies of The Rockies is a Denver-area speech, language, occupational, and physical ...
(Date:3/19/2020)... ... March 19, 2020 , ... Sucheta ... Executive Function, shares a free Student Learning Exercise: ExQ® Superpower Hour. ... teachers are seeking resources to help with the immediate need for activities that ...
(Date:3/19/2020)... ... March 19, 2020 , ... Van Dyk Health Care, which sold ... Caring, on October 3, 2018 and is not involved in the operations of these ... Family of Caring at Montclair. , “We are devastated to learn about the recent ...
Breaking Medicine News(10 mins):
(Date:3/30/2020)... HIALEAH, Fla. (PRWEB) , ... March 30, 2020 ... ... announced today that it is now offering 'Ask A Technician' service. , ... Tattoo Vanish Method LLC and added, "A certified technician at the Institute of ...
(Date:3/30/2020)... (PRWEB) , ... March 30, 2020 , ... ... and business as part of their business continuity and thebigword is making its ... , Clients of thebigword will be able to use the neural machine translation ...
(Date:3/28/2020)... ... March 27, 2020 , ... ... International has named Gary Gallant as its permanent CIO. In this executive ... technology vision, ensuring Isagenix can provide a smooth shopping experience for customers and ...
Breaking Medicine Technology:
Cached News: